Undisclosed immunology candidate
Autoimmune Disorder
PreclinicalActive
Key Facts
About Tyligand Bioscience
A clinical-stage biotech developing novel small molecule therapies for oncology and immunology through structure-based drug design.
View full company profileTherapeutic Areas
Other Autoimmune Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| Undisclosed Autoimmune Program | Replicate Bioscience | Pre-clinical |